Post Market Update- Markets take a breather ahead of RBI Verdict

Stocks in the news-

1. Strides Pharma arm gets USFDA EIR for its formulation’s facility at Chestnut Ridge, New York.

2. Concord Control Systems bagged KAVACH order worth Rs. 185 cr from Indian Railways.

Earnings-

1. Poly Medicure Q3 net profit down 17% YoY at Rs. 70.8 Cr.

2. J. Kumar Infraprojects Q3 net profit slipped 17.2% YoY at Rs. 82.8 Cr.

Indian indices-

On February 5, 2026, the Indian stock market snapped its three-day winning streak, ending the session deep in the red. Investors turned cautious and booked profits ahead of tomorrow's crucial RBI Monetary Policy announcement. The market remains under pressure with broad-based sectoral weakness led by IT, metals, realty, auto. At the end, Sensex declined by 0.60% or 503.76 points to 83,313.93. The Nifty plunged 0.52% or 133.20 points to 25,642.80.

Rupee ended at 90.36/$ Vs February 04, close of 90.44/$.

Buzzing stocks on BSE-

1. Concord Control Systems rose 1.91% to Rs. 2,613, following the company's announcement of a major order worth Rs 185.09 crore.

2. Trent advanced 2.95% to Rs. 4,131.0, after the company reported a 36.3% jumped in standalone net profit to Rs 639.71 crore in Q3 FY26 over Q3 FY25.

3. Force Motors rose 5.04% to Rs. 21,074.50 after the company reported a 252.1% year-on-year surge in consolidated net profit to Rs 406.15 crore in Q3 FY26, compared with Rs 115.34 crore in the corresponding quarter last year.

4. Parag Milk Foods slumped 7.99% to Rs. 241.80, after the company reported 18% drop in consolidated to Rs 30 crore in Q3 FY26 as compared with Q3 FY25.

Global Signals-

Asia-Pacific were lower, tracking Wall Street losses as the tech sell-off gained momentum.

European stock market opened lower as traders assessed regional earnings reports.